Send us a text

Welcome to The Oncology Journal Club Podcast Series 3
Hosted by Professor Craig Underhill, Dr Kate Clarke & Professor Christopher Jackson | Proudly produced by The Oncology Network

Kate Clarke takes over hosting duties!

Join our expert trio — Professor Craig Underhill, Dr Kate Clarke and Professor Christopher Jackson — for the usual OJC antics in Part 2 of our ESMO Special.

Craig talks us through the GU and lung highlights, while the team each share their top ‘practice-changing’ abstracts. Plus, CJ chats with Susie Stanway about the upcoming London Global Cancer Week.

Expect nuanced analysis, sharp insights and the occasional cheeky joke along the way.

To learn more about The Oncology Network, subscribe to our free weekly Newsletter and listen to other fantastic podcasts, visit our website: www.oncologynetwork.com.au. You'll also find the Show Notes on the website with links to the abstracts, bios of our hosts and a downloadable Bingo Card😂

Send us a text

Welcome to The Oncology Journal Club Podcast Series 3
Hosted by Professor Craig Underhill, Dr Kate Clarke & Professor Christopher Jackson | Proudly produced by The Oncology Network

Are you ready for some ESMO Bingo? Yes—it’s that time of year again!

Join our expert hosts Professor Craig Underhill, Dr. Kate Clarke and Professor Christopher Jackson for the usual OJC antics. 

This is Part 1 of our ESMO Special, where the team cover ovarian, breast, melanoma and GI. Expect the usual nuanced analysis and a few naughty jokes along the way.

To learn more about The Oncology Network, subscribe to our free weekly Newsletter and listen to other fantastic podcasts, visit our website: www.oncologynetwork.com.au. You'll also find the Show Notes on the website with links to the abstracts, bios of our hosts and a downloadable Bingo Card😂

Send us a text

Welcome to Episode 29 of The Oncology Podcast’s Experts On Point series, brought to you by The Oncology Network.

AGITG ASM 2025 Special | 24–27 November | Tarntanya (Adelaide), South Australia

The most exciting ideas in GI oncology rarely come from just one room—or even one country. In this episode, host Rachael Babin sits down with Associate Professor Sina Vatandoust, Convenor of the AGITG 2025 ASM, and Associate Professor Margaret Lee, one of this year’s local speakers. Together, they share a preview of the upcoming meeting and explore how collaboration across Australia, the Asia–Pacific and beyond is helping turn promising concepts into clinical trials that truly make a difference.

Expect discussion on some of the key themes from this year’s program, including early-onset cancer, global oncology insights and radiation oncology breakthroughs—all with survivorship at the heart of the conversation.

We hope you enjoy the episode.

For news and podcast updates subscribe to The Oncology Newsletter,  a free weekly publication for healthcare professionals with an interest in oncology. Click here to subscribe.

PART OF THE ONCOLOGY NETWORK... Join Us

Send us a text

Welcome to The Oncology Journal Club Podcast Series 3
Hosted by Professor Craig Underhill, Dr Kate Clarke & Professor Christopher Jackson | Proudly produced by The Oncology Network

Welcome to Episode 7 of The Oncology Journal Club podcast. This is where we take a famously different approach to oncology research.

Join our expert hosts as they navigate the latest developments with their trademark blend of critical analysis, clinical wisdom and humour. With this in mind please note: Warning: This episode does contain some strong language.

This week, Kate kicks us off with her report from the ESMO GI meeting with her key highlights.

Craig sparks a fascinating discussion about robotic surgery.

And CJ takes up a listener’s suggestion and talks us through the ATOMIC study. 

And of course, we’ve also got our regular PBS Updates and Blow Your Own Trumpet papers.

To learn more about The Oncology Network, subscribe to our free weekly Newsletter and listen to other fantastic podcasts, visit our website: www.oncologynetwork.com.au. You'll also find the Show Notes on the website with links to papers, a transcript and bios of our hosts.

Send us a text

Welcome to the latest Series of Supportive Care Matters, a podcast hosted by Medical Oncologist and International Cancer Survivorship Expert, Professor Bogda Koczwara AM.

"If it were a pill, we would all want it." This powerful opening statement captures the essence of ground-breaking research that's transforming our understanding of cancer survivorship care. The CHALLENGE Study has delivered what many considered impossible: definitive evidence that structured exercise significantly extends the lives of colorectal cancer survivors.

The results are nothing short of remarkable. Colorectal cancer patients who participated in a structured exercise program for three years after completing surgery and chemotherapy showed an 80% disease-free survival rate at five years, compared to 74% in those who received only health education materials. The results showed that structured exercise provides a significantly longer disease-free survival. Even more impressive, overall survival improved from 83% to 90% - a 37% decrease in risk. To put this in perspective, for every 14 patients who followed the exercise program, one additional life was saved.

What makes this intervention unique is its sophisticated approach to behaviour change. Participants received individualised exercise prescriptions targeting 150 minutes of moderate aerobic activity weekly, combined with regular supervision and motivational support. Exercise physiologists conducted environmental scans to identify accessible opportunities, established accountability through regular check-ins and helped participants overcome barriers to physical activity. This wasn't simply about telling people to exercise - it was about teaching them how to make sustainable lifestyle changes.

The implications for clinical practice are profound. To discuss this ground-breaking paper in detail, Professor Bogda Koczwara is joined by the Australian Principal Investigators - Professor Haryana Dhillon and Professor Janette Vardy.

Visit www.oncologynews.com.au for show notes and more information about Supportive Care Matters.

This conversation is proudly produced by the Podcast Team at The Oncology Podcast, part of the Oncology Media Group Australia.

Send us a text

Proudly produced by The Oncology Network

When does aggressive cancer treatment shift from beneficial to harmful? This powerful conversation between Professor Nathan Cherny and Professor Christopher Jackson tackles one of oncology's most challenging ethical dilemmas – overtreatment at the end of life.

Drawing on his extensive experience and research, Professor Cherny illuminates the complex factors driving excessive treatment, from departmental culture to cognitive biases. 

"Oncologists need to learn not only when to treat, but when not to treat," he emphasises, highlighting how treatment decisions for poor-performance status patients with resistant disease require particular scrutiny. 

The discussion reveals eye-opening research showing patients might consider additional treatment worthwhile only if it provided 12-18 months of quality life – far beyond what late-line therapies typically deliver.

Throughout the conversation, both oncologists acknowledge the delicate balance between appropriate intervention and knowing when to step back. Professor Cherny offers practical guidance for reframing hope beyond treatment response and recognising that courage exists not only in pursuing another treatment but also in saying "enough." This nuanced exploration of patient-centred decision-making provides a valuable perspective for clinicians, patients, and families navigating cancer's most difficult moments.

Join our community at oncologynetwork.com.au for more insightful discussions and subscribe to our weekly publication The Oncology Newsletter to stay informed on the latest advancements in cancer care.

The Oncology Podcast - An Australian Oncology Perspective

Send us a text

Welcome to The Oncology Journal Club Podcast Series 3
Hosted by Professor Craig Underhill, Dr Kate Clarke & Professor Christopher Jackson | Proudly produced by The Oncology Network

Welcome to Episode 6 of The Oncology Journal Club podcast. This is where we take a famously different approach to oncology research.

Has non-operative management finally found its place in treating certain cancers? This episode unpacks compelling new data that might challenge the surgeon's traditional role for some patients with mismatch repair deficient tumours. While rectal cancer patients show remarkable complete response rates to immunotherapy, the story gets more complex across different cancer types – raising fascinating questions about tumour biology, patient selection and the future of organ preservation.

We explore the delicate art of discussing immunotherapy outcomes with patients, navigating that narrow path between hope and realism. When treatments occasionally produce dramatic responses but more commonly offer limited benefits, how do oncologists communicate effectively without creating unrealistic expectations? Our hosts share practical strategies for these challenging conversations, emphasising that truly patient-centred care requires ongoing dialogue about prognosis.

The oncology research world is evolving too, with updated CONSORT and SPIRIT guidelines transforming how clinical trials are designed and reported. These frameworks now mandate greater transparency, clearer safety reporting and increased patient involvement in study design – potentially leading to more trustworthy and applicable research outcomes.

Plus, we examine an intriguing Chinese trial showing remarkable survival benefits from low-dose continuous capecitabine combined with aromatase inhibitors for metastatic breast cancer – a potential game-changer for resource-limited settings.

From this year's AACR meeting, we highlight what might be the first change in standard of care for locally advanced head and neck cancer in two decades, along with promising targeted therapies for specific molecular subtypes of lung cancer. 

Join our expert hosts Professor Craig Underhill, Dr. Kate Clarke and Professor Christopher Jackson as they navigate these developments with their trademark blend of critical analysis, clinical wisdom and humour. 

Subscribe to The Oncology Newsletter to stay informed about the evolving landscape of oncology care and research.

For links to the abstracts and bios of our hosts, head to the show notes on oncologynetwork.com.au.

Send us a text

Welcome to The Oncology Journal Club Podcast Series 3
Hosted by Professor Craig Underhill, Dr Kate Clarke & Professor Christopher Jackson | Proudly produced by The Oncology Network

Welcome to the Oncology Journal Club ASCO 2025 Special – Part 2! This is where we take a famously different approach to oncology research.

If you're after an enlightening and entertaining take on this year’s ASCO meeting, the OJC team has you covered – blending expert analysis with trademark humour.

Our hosts go beyond the standard presentations to explore what the research really means for clinical practice.

For links to the abstracts and bios of our hosts, head to the show notes on oncologynetwork.com.au.

Subscribe to The Oncology Newsletter for regular updates on the latest cancer research and join our community at oncologynetwork.com.au.

Send us a text

Welcome to The Oncology Journal Club Podcast Series 3
Hosted by Professor Craig Underhill, Dr Kate Clarke & Professor Christopher Jackson | Proudly produced by The Oncology Network

Welcome to the Oncology Journal Club ASCO 2025 Special – Part 1! This is where we take a famously different approach to oncology research.

If you're after an enlightening and entertaining take on this year’s ASCO meeting, the OJC team has you covered – blending expert analysis with trademark humour.

Our hosts go beyond the standard presentations to explore what the research really means for clinical practice.

For links to the abstracts and bios of our hosts, head to the show notes on oncologynetwork.com.au.

Subscribe to The Oncology Newsletter for regular updates on the latest cancer research and join our community at oncologynetwork.com.au.

Send us a text

Welcome to the latest Series of Supportive Care Matters, a podcast hosted by Medical Oncologist and International Cancer Survivorship Expert, Professor Bogda Koczwara AM.

The landscape of cancer survivorship is evolving before our eyes. As treatment advances allow people with metastatic cancer to live longer, we're witnessing the emergence of a population that exists in what medical oncologist Dr Lori Spoozak calls "the place in between" – not curable but not actively dying.

In this eye-opening conversation, researchers Associate Professor Nick Hart and Dr. Andrea Smith (who herself lives with metastatic breast cancer) explore the unique challenges faced by those living with advanced cancer. While survivorship programs have traditionally focused on post-treatment care, metastatic patients are typically on treatment for life, navigating constant healthcare interactions, accumulating side effects and facing the certainty rather than just the fear of disease progression.

The discussion reveals how metastatic cancer patients have often fallen through the cracks – excluded from survivorship programs yet not appropriately served by palliative care services that focus primarily on end-of-life needs. This growing population faces what Dr. Smith describes as supportive care needs "on steroids" – intensified physical, psychological, financial and practical challenges that require specialised approaches.

Hart and Smith share their ground-breaking work developing the first international standards for metastatic cancer survivorship care, now translated into 14 languages to guide implementation worldwide. They emphasise that improving care requires action on multiple fronts: better education for healthcare professionals, redesigned care models, dedicated peer support programs and recognition that survivorship care is everyone's responsibility rather than the domain of any single provider.

Whether you're a healthcare professional, researcher, patient advocate or someone living with cancer, this conversation challenges conventional thinking about survivorship and offers a compelling vision for more inclusive, responsive care. Discover why supporting those living for years with incurable cancer represents both an urgent challenge and a tremendous opportunity to enhance quality of life for this overlooked population.

Visit www.oncologynews.com.au for show notes and more information about Supportive Care Matters.

This conversation is proudly produced by the Podcast Team at The Oncology Podcast, part of the Oncology Media Group Australia.